Double interruption of antiplatelet therapy and tirofiban "bridging" for lung cancer resection.
F
F
Controtto
P
P
Scacciatella
R
R
Cristofori
C
C
Grasso
M
M
D'Amico
M
M
Pennone
S
S
Marra
D054058:Acute Coronary Syndrome / Q000628:therapy*; D000368:Aged; D001707:Biopsy, Needle; D000077144:Clopidogrel; D023903:Coronary Restenosis / Q000628:therapy; D004334:Drug Administration Schedule; D057915:Drug Substitution / Q000379:methods*; D054855:Drug-Eluting Stents / Q000009:adverse effects; D006801:Humans; D008168:Lung / Q000473:pathology / Q000601:surgery; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D019233:Retreatment / Q000379:methods; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077466:Tirofiban; D014443:Tyrosine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D010975:Platelet Aggregation Inhibitors; D014443:Tyrosine; D000077144:Clopidogrel; D000077466:Tirofiban; D013988:Ticlopidine